MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9

British Journal of Cancer

Volumn 110, Issue 12, 2014, Pages 2945-2954

  Jia, A Y ^a   Castillo Martin, M ^b   Bonal, D M ^b   Sanchez Carbayo M ^c   Silva, J M ^a   Cordon Cardo, C ^b,d  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c CIC BIOGUNE   (Spain)

^d Howard Hughes Medical Institute   (United States)

Author keywords

ADAM9; Bladder cancer; Invasion; MicroRNA; MiR 126

Indexed keywords

ADAM PROTEIN; ADAM9 PROTEIN; MICRORNA 126; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR INVASION; UPREGULATION;

ADAM PROTEINS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; PROGNOSIS; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84902543932     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.245     Document Type: Article

References (38)

1. Blobel CP (2005) ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6(1): 32-43
2. Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman JG, Bose S, Wang SI, Parsons R, Sidransky D (1998) Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene 16(24): 3215-3218. (Pubitemid 28318794
3. Cairns P, Proctor AJ, Knowles MA (1991) Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6(12): 2305-2309. (Pubitemid 21924078
4. Chapman EJ, Harnden P, Chambers P, Johnston C, Knowles MA (2005) Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Clin Cancer Res 11(16): 5740-5747. (Pubitemid 41170298
5. Chen H, Miao R, Fan J, Han Z, Wu J, Qiu G, Tang H, Peng Z (2013) Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma. Clin Exp Metastasis 30(5): 651-658
6. Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M (2012) Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 30(4): 434-443
7. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102(5): 883-891
8. Cordon-Cardo C (2008) Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 218: 154-165
9. Duffy MJ, McKiernan E, O'Donovan N, McGowan PM (2009) Role of ADAMs in cancer formation and progression. Clin Cancer Res 15(4): 1140-1144
10. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6(4): 259-269
11. Fleige S, Pfaffl MW (2006) RNA integrity and the effect on the real-Time qRT-PCR performance. Mol Aspects Med 27(2-3): 126-139
12. Goebell PJ, Knowles MA (2010) Bladder cancer or bladder cancers?. Genetically distinct malignant conditions of the urothelium. Urol Oncol 28(4): 409-428
13. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T (2012) MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 10(1): 3-10
14. He L, Hannon GJ (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5(7): 522-531. (Pubitemid 38868508
15. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2012) Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One 7(11): E51056
16. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2009) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute: Bethesda, M.D.
17. Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sanchez-Carbayo M, Silva JM, Cordon-Cardo C (2013) A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. Am J Pathol 182(4): 1171-1179
18. Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clement B, Theret N (2003) ADAM12 in human liver cancers: TGF-betaregulated expression in stellate cells is associated with matrix remodeling. Hepatology 37(5): 1056-1066. (Pubitemid 36538682
19. Li M, Zhang ZF, Reuter VE, Cordon-Cardo C (1996) Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol 149(1): 229-235. (Pubitemid 26230994
20. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai ZL, Dahiya R (2012) MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One 7(10): E46743
21. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A (2005) A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 65(11): 4728-4738. (Pubitemid 40740809
22. Meyer SU, Pfaffl MW, Ulbrich SE (2010) Normalization strategies for microRNA profiling experiments: A 'normal' way to a hidden layer of complexity?. Biotechnol Lett 32(12): 1777-1788
23. Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y (2013) Replacement treatment with microRNA-143 and-145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 328(2): 353-361
24. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ (2003) Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 105(6): 754-761. (Pubitemid 36706097
25. Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C (1999) Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol 155(1): 105-113. (Pubitemid 29318709
26. Peduto L, Reuter VE, Shaffer DR, Scher HI, Blobel CP (2005) Critical function for ADAM9 in mouse prostate cancer. Cancer Res 65(20): 9312-9319. (Pubitemid 41507998
27. Presti Jr. JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C (1991) Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51(19): 5405-5409
28. Sanfiorenzo C, Ilie MI, Belaid A, Barlesi F, Mouroux J, Marquette CH, Brest P, Hofman P (2013) Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One 8(1): E54596
29. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, Kirita T, Kuniyasu H (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107(4): 700-706
30. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2): 199-208. (Pubitemid 37329583
31. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N (2004) Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 64(12): 4190-4196. (Pubitemid 38802422
32. Simoneau M, LaRue H, Aboulkassim TO, Meyer F, Moore L, Fradet Y (2000) Chromosome 9 deletions and recurrence of superficial bladder cancer: Identification of four regions of prognostic interest. Oncogene 19(54): 6317-6323. (Pubitemid 32641845
33. Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, Anderson C, Johnstone P, Petros JA, Marshall FF, Zhau HE, Chung LW (2006) Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res 66(19): 9519-9526. (Pubitemid 44623650
34. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175): 147-152
35. Yamasaki T, Yoshino H, Enokida H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Fuse M, Seki N, Nakagawa M (2012) Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol 40(6): 1821-1830
36. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M (2011) The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104(5): 808-818
37. Yoshino H, Enokida H, Chiyomaru T, Tatarano S, Hidaka H, Yamasaki T, Gotannda T, Tachiwada T, Nohata N, Yamane T, Seki N, Nakagawa M (2012) Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun 417(1): 588-593
38. Zhang W, Dahlberg JE, Tam W (2007) MicroRNAs in tumorigenesis: A primer. Am J Pathol 171(3): 728-738. (Pubitemid 47440972.